The treatment of Cancer Risk Reduction & Food Allergy with vitamins

Cancer Risk Reduction and Food Allergy: Mitamins custom make quality formulas for the treatment of Cancer Risk Reduction & Food Allergy with vitamins. A Cancer Risk Reduction & Food Allergy formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cancer Risk Reduction and Food Allergy

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    500
    mg
    833%
    Vitamin E
    100
    IU
    333%
    Pantothenic Acid
    100
    mg
    1000%
    Lactobacillus acidolphilus
    500
    mg
    *
    CoQ-10
    15
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    200
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    L-Glutamine
    200
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cancer Risk Reduction and Food Allergy
Monthly Cost: $35.21
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Cancer Risk Reduction and Food Allergy Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
FDA Experts Urge Ban on Cold Medicines for Young Children (HealthDay)
U.S. health experts on Friday urged the federal Food and Drug Administration to consider banning the sale of over-the-counter cough and cold medicines for young children.
Ardea Biosciences' Lead MEK Inhibitor, RDEA119, To Enter Human Clinical Trials In Advanced Cancer Patients
Ardea Biosciences, Inc. (Pink Sheets: ARDC), a company focused on the discovery and development of small-molecule therapeutics for the treatment of viral diseases, cancer and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) granted safe-to-proceed status to the Investigational New Drug (IND) application for RDEA119, enabling initiation of a Phase 1 clinical trial in advanced cancer patients.
This information concerning the support of Cancer Risk Reduction and Food Allergy treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Cancer & Chemo  Cancer Risk Reduction  Cancer Risk Reduction and Food Allergy
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments